These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20676839)

  • 1. Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure.
    Kimura H; Hiramitsu S; Miyagishima K; Mori K; Yoda R; Kato S; Kato Y; Morimoto S; Hishida H; Ozaki Y
    Heart Vessels; 2010 Jul; 25(4):306-12. PubMed ID: 20676839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Hamaguchi S; Tsuchihashi-Makaya M; Kinugawa S; Yokota T; Takeshita A; Yokoshiki H; Tsutsui H;
    Circ J; 2009 Oct; 73(10):1901-8. PubMed ID: 19652398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated troponin T on discharge predicts poor outcome of decompensated heart failure.
    Koide K; Yoshikawa T; Nagatomo Y; Kohsaka S; Anzai T; Meguro T; Ogawa S
    Heart Vessels; 2010 May; 25(3):217-22. PubMed ID: 20512449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.
    Ueno H; Nakayama M; Kojima S; Kusuhara K; Nagayoshi Y; Yamamuro M; Nishijima T; Usuku H; Kaikita K; Sumida H; Yamabe H; Sugiyama S; Yoshimura M; Ogawa H
    Heart Vessels; 2008 Jul; 23(4):243-8. PubMed ID: 18649054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.
    Yamashita T; Yoshida T; Ogawa T; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2011 Dec; 15(6):831-40. PubMed ID: 21800234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction.
    Maréchaux S; Six-Carpentier MM; Bouabdallaoui N; Montaigne D; Bauchart JJ; Mouquet F; Auffray JL; Le Tourneau T; Asseman P; LeJemtel TH; Ennezat PV
    Heart Vessels; 2011 May; 26(3):313-20. PubMed ID: 21063875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
    Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
    Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.
    Penne EL; van der Weerd NC; Grooteman MP; Mazairac AH; van den Dorpel MA; Nubé MJ; Bots ML; Lévesque R; ter Wee PM; Blankestijn PJ;
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):281-9. PubMed ID: 21030579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure.
    Petretta M; Scopacasa F; Fontanella L; Carlomagno A; Baldissara M; de Simone A; Petretta MP; Bonaduce D
    J Cardiovasc Med (Hagerstown); 2007 Nov; 8(11):909-16. PubMed ID: 17906476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure.
    Gardner RS; Chong KS; O'Meara E; Jardine A; Ford I; McDonagh TA
    Eur Heart J; 2007 Dec; 28(24):3027-33. PubMed ID: 17967819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.
    Brisco MA; Coca SG; Chen J; Owens AT; McCauley BD; Kimmel SE; Testani JM
    Circ Heart Fail; 2013 Mar; 6(2):233-9. PubMed ID: 23325460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.
    Silverberg DS; Wexler D; Blum M; Iaina A
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S93-102. PubMed ID: 12940539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
    Tang WH; Tong W; Jain A; Francis GS; Harris CM; Young JB
    J Am Coll Cardiol; 2008 Feb; 51(5):569-76. PubMed ID: 18237687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.
    Sato Y; Fujimoto S; Konta T; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Kasahara M; Shibagaki Y; Asahi K; Watanabe T
    Clin Exp Nephrol; 2018 Apr; 22(2):388-394. PubMed ID: 28815319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.